In addition to its own drug discovery and development efforts, FRI works in close collaboration with world leading academic laboratories to translate new ideas emerging from basic research into innovative medicines.

We have built long term relationships with key opinion leaders in each of our therapeutic areas of interest and regularly seek expertise from specialists to help guide and advance our translational research programs.

While Ferring is recognized as a leader in the field of peptide therapeutics we are constantly looking to our academic and biotechnology colleagues to access cutting edge technologies that can be applied to the development of our first-in-class peptide therapeutics.